UNC13D ELISA Kit
UNC13D
Reaktivität: Human
Colorimetric
Sandwich ELISA
0.313 ng/mL - 20 ng/mL
Plasma, Serum, Tissue Homogenate
-
- Target Alle UNC13D Produkte
- UNC13D (Unc-13 Homolog D (UNC13D))
- Reaktivität
- Human
- Nachweismethode
- Colorimetric
- Methodentyp
- Sandwich ELISA
- Detektionsbereich
- 0.313 ng/mL - 20 ng/mL
- Untere Nachweisgrenze
- 0.313 ng/mL
- Applikation
- ELISA
- Verwendungszweck
- Human UNC13D/Munc13-4 ELISA Kit is an ELISA Kit against UNC13D/Munc13-4.
- Proben
- Plasma, Serum, Tissue Homogenate
- Analytische Methode
- Quantitative
- Sensitivität
- < 0.188 ng/mL
-
- Applikationshinweise
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
Standard Form: Lyophilized
- Plattentyp
- Pre-coated
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
- Haltbarkeit
- 6 months
-
- Target Alle UNC13D Produkte
- UNC13D (Unc-13 Homolog D (UNC13D))
- Andere Bezeichnung
- UNC13D/Munc13-4 (UNC13D Produkte)
- Synonyme
- FHL3 ELISA Kit, HLH3 ELISA Kit, HPLH3 ELISA Kit, Munc13-4 ELISA Kit, UNC13D ELISA Kit, 2610108D09Rik ELISA Kit, Jinx ELISA Kit, mFLJ00067 ELISA Kit, Unc13h4 ELISA Kit, BIGH3 ELISA Kit, CDB1 ELISA Kit, CDG2 ELISA Kit, CDGG1 ELISA Kit, CSD ELISA Kit, CSD1 ELISA Kit, CSD2 ELISA Kit, CSD3 ELISA Kit, EBMD ELISA Kit, LCD1 ELISA Kit, unc-13 homolog D ELISA Kit, unc-13 homolog D (C. elegans) ELISA Kit, transforming growth factor beta induced ELISA Kit, UNC13D ELISA Kit, Unc13d ELISA Kit, TGFBI ELISA Kit, unc13d ELISA Kit, un13d ELISA Kit
- UniProt
- Q70J99
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-
Sie sind hier:
